DataMeds AI, Inc.
Tampa, Florida, United States · Artificial Intelligence, Biotechnology, Health Care
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The firm focuses on advancing healthcare technology and solutions for independent pharmacists. With a recent management upgrade, Wellgistics aims to become a force in blockchain-enabled medication tracking. They are enhancing their capabilities to meet
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Tampa, Florida, United States
- Employees
- Unknown
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Public (MEDS)
- Website
- datamedsai.com
Recent activity at DataMeds AI, Inc.
- : SEC 8-K (1.01): On November 16, 2026, DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities, Inc. This agreement allows the Company to offer and sell shares of its common stock through the Sales Agent, with no obligation to sell any shares. The shares will be sold at market prices, and a 3.0% commission on gross proceeds will be paid to the Sales Agent. The Sales Agreement includes conditions for termination by either party and customary indemnifications, and it is being offered under the Company’s prior registration statement effective since May 7, 2026.
- : SEC 8-K (1.02): On November 3, 2026, DataMEDS AI, Inc. terminated its Second Amended and Restated Letter of Intent (LOI) that was originally established on October 21, 2026, with multiple parties including EOS Technology Holdings, Inc., Scilex Holding Company, and Datavault AI Inc. The LOI had outlined plans for the acquisition of intellectual property assets and expansions involving several affiliated companies in exchange for shares of DataMEDS' common stock. The termination is immediate and does not affect existing agreements with Datavault or any other arrangements. This decision indicates a strategic shift for DataMEDS AI as it moves away from the proposed transactions with these partners.
- : DataMEDS AI, Inc. to Acquire Key Health Technology Assets
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About DataMeds AI, Inc.: questions and answers
What does DataMeds AI, Inc. do?
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The firm focuses on advancing healthcare technology and solutions for independent pharmacists. With a recent management upgrade, Wellgistics aims to become a force in blockchain-enabled medication tracking. They are enhancing their capabilities to meet
Where is DataMeds AI, Inc. headquartered?
DataMeds AI, Inc. is headquartered in Tampa, Florida, United States.
What is the latest news on DataMeds AI, Inc.?
On Nov 5, 2026, SEC 8-K (1.01): On November 16, 2026, DataMEDS AI, Inc. entered into an ATM sales agreement with Dawson James Securities, Inc. This agreement allows the Company to offer and sell shares of its common stock through the Sales Agent, with no obligation to sell any shares. The shares will be sold at mar
Is DataMeds AI, Inc. a public company?
Yes. DataMeds AI, Inc. is publicly traded under the ticker MEDS.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy